Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients

Liver transplantation (LT) is a curative treatment for early-stage hepatocellular carcinoma (HCC) unsuitable for surgical resection. However, tumor recurrence (TR) rates range from 8% to 20% despite strict selection criteria. The validation of new prognostic tools, such as pre-MORAL or RETREAT risks...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuadrado, Antonio, Fortea, José Ignacio, Rodríguez-Lope, Carlos, Puente, Ángela, Fernández-Vilchez, Vanesa, Echavarria, Victor Jose, Castillo Suescun, Federico José, Fernández, Roberto, Echeverri, Juan Andrés, Achalandabaso, Mar, Toledo, Enrique, Pellón, Raúl, Rodríguez Sanjuan, Juan Carlos, Crespo, Javier, Fábrega, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488177/
https://www.ncbi.nlm.nih.gov/pubmed/37685524
http://dx.doi.org/10.3390/jcm12175457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488177/
https://www.ncbi.nlm.nih.gov/pubmed/37685524
http://dx.doi.org/10.3390/jcm12175457

Ejemplares similares